Literature DB >> 26395891

[The metastatic niche. Mechanisms and prognostic implications].

M H Muders1, G B Baretton2.   

Abstract

Disseminated tumor cells require a special microenvironment to form metastases. This metastatic niche is organ specific and forms prior to the establishment of visible metastases. The niche is characterized by vascular remodeling and bone marrow-derived cells which have migrated into it. Studies by other groups and our own results have already shown that intranodal lymphangiogenesis is an important prerequisite for regional lymph node metastases in rectal cancer patients, and can be used as a prognostic marker for progression-free survival. Niche cells such as endothelia secrete factors that attract tumor and bone marrow-derived cells. CXCL12 is one of these factors. CXCL12 activates the CXCR4 chemokine axis and induces migration along its gradient. Several factors, such as hypoxia, have been described to regulate CXCR4 function and surface expression on tumor cells. Low molecular weight agents have been used to block CXCR4 activation. This review focuses on the function and regulation of CXCR4 and its ligand CXCL12 in metastases formation. It also discusses potential options for therapeutic blockage.

Entities:  

Keywords:  Lymph node metastasis; Lymph nodes, locoregional; Lymphatic vessels, intranodal; Neuropilin; Survival, progression-free

Mesh:

Substances:

Year:  2015        PMID: 26395891     DOI: 10.1007/s00292-015-0079-y

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  30 in total

1.  Autophagy control by the VEGF-C/NRP-2 axis in cancer and its implication for treatment resistance.

Authors:  Marissa J Stanton; Samikshan Dutta; Heyu Zhang; Navatha S Polavaram; Alexey A Leontovich; Pia Hönscheid; Frank A Sinicrope; Donald J Tindall; Michael H Muders; Kaustubh Datta
Journal:  Cancer Res       Date:  2012-11-13       Impact factor: 12.701

2.  Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients.

Authors:  B Keck; S Wach; H Taubert; S Zeiler; O J Ott; F Kunath; A Hartmann; S Bertz; C Weiss; P Hönscheid; S Schellenburg; C Rödel; G B Baretton; R Sauer; R Fietkau; B Wullich; F S Krause; K Datta; M H Muders
Journal:  Int J Cancer       Date:  2014-06-12       Impact factor: 7.396

3.  Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha.

Authors:  Roderick J Phillips; Javier Mestas; Mehrnaz Gharaee-Kermani; Marie D Burdick; Antonio Sica; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  J Biol Chem       Date:  2005-03-31       Impact factor: 5.157

4.  VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites.

Authors:  Satoshi Hirakawa; Lawrence F Brown; Shohta Kodama; Karri Paavonen; Kari Alitalo; Michael Detmar
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

5.  Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia.

Authors:  Steven P Treon; Yang Cao; Lian Xu; Guang Yang; Xia Liu; Zachary R Hunter
Journal:  Blood       Date:  2014-02-19       Impact factor: 22.113

6.  Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer.

Authors:  Carl C Schimanski; Stefan Schwald; Nektaria Simiantonaki; Caren Jayasinghe; Ursula Gönner; Vanessa Wilsberg; Theodor Junginger; Martin R Berger; Peter R Galle; Markus Moehler
Journal:  Clin Cancer Res       Date:  2005-03-01       Impact factor: 12.531

7.  A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

Authors:  C C Bleul; R C Fuhlbrigge; J M Casasnovas; A Aiuti; T A Springer
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

8.  NF-κB signaling pathway confers neuroblastoma cells migration and invasion ability via the regulation of CXCR4.

Authors:  Yunlai Zhi; Yuhe Duan; Xianjun Zhou; Xiaofeng Yin; Ge Guan; Hong Zhang; Qian Dong; Kun Yang
Journal:  Med Sci Monit       Date:  2014-12-21

9.  Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression.

Authors:  Hironao Yasuoka; Rieko Kodama; Masahiko Tsujimoto; Katsuhide Yoshidome; Hiroki Akamatsu; Masaaki Nakahara; Michiya Inagaki; Tokio Sanke; Yasushi Nakamura
Journal:  BMC Cancer       Date:  2009-07-07       Impact factor: 4.430

10.  Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070.

Authors:  G O'Boyle; I Swidenbank; H Marshall; C E Barker; J Armstrong; S A White; S P Fricker; R Plummer; M Wright; P E Lovat
Journal:  Br J Cancer       Date:  2013-03-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.